Condition: Brain Tumor · Kidney Tumor · Neuroblastoma · Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
To engineer immune organoids from pediatric patient tissues using induced-pluripotent stem cells (iPSC)
This description comes directly from the study's public registry record.
Claudia PASQUALINI, MD · +33 (0)1 42 11 55 31 · claudia.pasqualini@gustaveroussy.fr
Jérémy MIONE, MS · +33 (0)1 42 11 42 11 · jeremy.mione@gustaveroussy.fr
Always discuss trial participation with your own doctor first.
| Gustave Roussy | Villejuif, France | Recruiting |
| Hopital Necker | Paris, Île-de-France Region, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05890781